2-[2-(1-Methylethoxy)ethyl]-pyridine, 98.0%, 100mg

3-(ethoxycarbonyl)-5-methyl-1-(2-methyl-5-nitrophenyl)-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 5g

tert-butyl 4-amino-1,4'-bipiperidine-1'-carboxylate, 95.0%, 250mg

2-Methylaminomethyl-1,3-dioxolane, 98%, 1g

Olodaterol Hydrochloride, 95%, 10mg

4-Hydroxy-3-methoxy-5-nitrobenzonitrile, 98%, 100mg

(S)-Propylene Carbonate>98.0%(GC)25g

Butanedioic acid, 2-hydroxy-, (2S)-, compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1), 99%, 5g

(R)-4-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride, 95.0%, 100mg

Ethyl 2-(4-acetyl-1H-1,2,3-triazol-1-yl)acetate, 98%, 250mg

Tiapride, 98%, 1g

4,5-Dibromo-2-methyl-2H-1,2,3-triazole, 95.0%, 100mg

Anti-Influenza A Virus Neuraminidase N2 Monoclonal Antibody (Preservative : 0.05% NaN3, Stabilizer : 1% BSA)0.2mL